top of page

Search Results

Search results for "Cancer Research UK"

Results found for "Cancer Research UK"

  • Dr. Bruno Giros | Dr. GPCR Ecosystem

    University in Paris and a short internship at Genentech Inc. in South San Francisco, he joined the CNRS as a Research Since 2008, he has arrived at McGill University as a Canada Research Chair. At McGill, his laboratory has two main axes of research: 1) Studying interindividual vulnerability to trainees obtain positions in the academic or private sectors or are currently pursuing postdoctoral research Bruno Giros on the web Dougles Research Center LinkedIn Google Scholar Researchgate Dr.

  • Dr. Timo De Groof | Dr. GPCR Ecosystem

    During his last year of studies, Timo performed research in the biopharmaceutical company Argen X and Raimond Heukers , developed a nanobody platform within the research group and used this platform to develop During his Ph.D., he used these nanobodies as research tools, to investigate different GPCR conformations Starting from September 2019, Timo started working as a postdoctoral researcher at the Vrije Universiteit future, Timo hopes to combine his previous GPCR experience with his current focus to set up his own research

  • Robert Laprairie | Dr. GPCR Ecosystem

    Robert Laprairie is an Associate Professor and the Saskatchewan Research Chair in Drug Discovery and The focus of his research is the molecular pharmacology of cannabinoids and cannabinoid receptors. Investigator of the Year Awards from the British Pharmacological Society and International Cannabinoid Research Robert Laprairie on the web University of Saskatchewan Twitter Instagram ResearchGate Google Scholar

  • Dr. GPCR University Vault | Dr. GPCR Ecosystem

    Ultimate On-Demand GPCR Learning Library Every talk inside the University Vault represents years of research Valid until canceled Join Premium Now 🎓 Full GPCR University + 🔬 200+ expert talks 🗞️ Weekly research networking, AMAs & matchmaking 💡 Support open resources for the global GPCR field 🧠 Designed for researchers pause and re-watch complex presentations on signaling pathways has been crucial for advancing my own research is Evolving—Don't Fall Behind You don't need to attend every event to stay at the forefront of GPCR research

  • Dr. Jean Martin Beaulieu | Dr. GPCR Ecosystem

    Beaulieu was an associate professor and Canada Research Chair (Tier2) in the Department of Psychiatry Beaulieu’s research is aimed at understanding how cellular and molecular mechanisms regulated by psychoactive Translational validation is important to validate findings obtained from experimental models research In addition to basic research, the Beaulieu group is also actively implicated in translational research Jean Martin Beaulieu on the web University of Toronto Google Scholar LinkedIn ResearchGate Dr.

  • Dr. Raul Gainetdinov | Dr. GPCR Ecosystem

    Gainetdinov was a Senior Researcher in the Department of Neuroscience and Brain Technologies at the Italian Institute of Technology in Genova, Italy (2008-2016) and an Associate Research Professor in the Department joining the Department of Cell Biology in 1996 as a postdoc and becoming faculty at Duke in 2000, he researched Gainetdinov was included in the Web of Science (WOS) Highly Cited Researchers (HCR) list, representing Raul Gainetdinov on the web Saint-Petersburg State University Wikipedia Google Scholar Researchgate Google

  • Custom Molecules, Fluorescent Probes: When Chemists Think Like Biologists with Dr. Maria Majellaro from Celtarys | Dr. GPCR Ecosystem

    Discover how Celtarys Research is transforming GPCR assay development with fluorescent ligands in this GPCR means for the global research community. << Back to podcast list Strategic Partner(s) Custom Molecules Maria Majellaro, CSO of Celtarys Research, shares the story behind the company’s journey from academic GPCR and Celtarys, built on a shared commitment to empowering the GPCR research community. Jhonny Azuaje they laid the groundwork for the future creation of Celtarys Research.

  • University Pricing | Dr. GPCR Ecosystem

    All these benefits are designed to enhance your research experience and keep you informed about the latest GPCR University Your Professional Home in GPCR Science Join the community where GPCR researchers learn Valid until canceled Join Premium Today! One insight, one connection, one 'aha' moment — can save months of research time. Premium Membership Benefits Everything you need to stay at the forefront of GPCR research and advance

  • Dr. Graeme Milligan | Dr. GPCR Ecosystem

    Graeme Milligan Professor Graeme Milligan is Gardiner Professor of Biochemistry, Dean of Research, and His main research group centers on the function, structure, and regulation of G protein-coupled receptors Milligan has published more than 550 peer-reviewed articles and his research has been cited more than Graeme Milligan on the web University of Glasgow ResearchGate PubMed Orcid Google Scholar LinkedIn Dr

  • Debbie Hay: Class B GPCRs, RAMPs, and the Migraine Pharmacology Gap | Dr. GPCR Ecosystem

    Hay, who has studied RAMPs since they were first described and when working on them was a high-risk research Her research centers on the molecular pharmacology of class B GPCRs - specifically the calcitonin receptor She has worked across pharmaceutical, biotechnology, and academic settings, including a research placement For a condition affecting up to 20% of women worldwide, Hay notes, the research investment in understanding Debbie obtained a Ph.D. in Molecular Pharmacology from Imperial College London in the UK.

  • Self-Learning, Collaboration, and Delegation in Science with Dr. Badr Sokrat | Dr. GPCR Ecosystem

    At the end of 2023, I joined the research group of Dr. Nigel Bunnett at the NYU Pain Research Center as a postdoctoral researcher. My current research focuses on investigating GPCR signaling and trafficking in the context of inflammation Next Steps Badr will continue focusing his research on GPCRs involved in pain and inflammation during Yamina and Badr will create a virtual genealogical tree mapping the connections between researchers in

  • Pod-Be Our Guest - Public | Dr. GPCR Ecosystem

    GPCR Podcast Share Your Research. Inspire the GPCR Community. Every episode of the Dr. breakthrough discoveries, career paths in pharmacology and molecular biology, and how each guest’s research If you’re working on exciting GPCR-related research — from structural biology to drug discovery — we’ Share the latest scientific discoveries in the GPCR field through discussions with experts Provide researchers Can I reschedule or cancel our meeting? What should I expect during the recording process?

  • Recombinant Antibodies for GPCRs: A Challenge to the Community | Dr. GPCR Ecosystem

    Alexander Ball of GeneTex on the recombinant platform and validation strategy behind a challenge to GPCR researchers GeneTex is offering free samples of the recombinant antibodies to GPCR researchers in exchange for structured Ball puts it in his own words, the primary goal is to get these reagents tested and evaluated by GPCR researchers He transitioned from clinical medicine to academic research at UC Irvine, where he worked on protein Cancel anytime. Sign Up for Free

  • Tanishka S. Saraf | Dr. GPCR Ecosystem

    Saraf " My research focuses on evaluating and targeting serotonin 1A receptors for therapeutic outcomes Saraf on the web FRAXA Research Foundation Google Scholar ResearchGate LinkedIn Dr.

  • Dr. Bianca Plouffe | Dr. GPCR Ecosystem

    After obtaining a Postdoctoral Fellowship from the Canadian Institutes of Health Research in 2012, Bianca joined the research group of Prof Michel Bouvier at Université de Montréal. In 2018, Bianca was appointed Vice-Chancellor’s Fellow at Queen’s University Belfast to develop her research Bianca Plouffe on the web Queen's University Belfast website LinkedIn ResearchGate ORCID Dr.

  • Dr. Daniel Wacker | Dr. GPCR Ecosystem

    Roland Beckmann with a brief stay at Cambridge University, UK, working in the lab of the late Dr. Guenter Blobel , before starting my Ph.D. in 2009 at The Scripps Research Institute in La Jolla.

  • Pfleger: NanoBRET, Receptor Complexes, and the Translation of GPCR Pharmacology | Dr. GPCR Ecosystem

    Kevin Pfleger's research at the University of Western Australia sits at the intersection of assay technology His research centers on GPCR functional interactions, with a focus on arrestin signaling, receptor complex That is really why I think most people get into medical research. It's very humbling." Perkins Institute of Medical Research, Deputy Director of the Australian Research Council Centre for Harry Perkins Institute of Medical Research Dr.

  • Brendan Wilkins | Dr. GPCR Ecosystem

    Since then, Brendan worked as a research assistant at the Victor Chang Cardiac Research Institute where post-doctoral positions to begin in mid-2024" Brendan Wilkins on the web UNSW Sydney Google Scholar ResearchGate

  • Kathryn Livingston: Allosteric Opioid Modulators and Receptor Signaling Beyond the Membrane | Dr. GPCR Ecosystem

    allosteric opioid modulators, receptor internalization, and navigating the transition from academic GPCR research Livingston's PhD research at the University of Michigan addressed this systematically - mapping selectivity and analytical instrumentation - to Product Manager, translating customer research needs into commercial a career model for GPCR-trained scientists The structural complementarity of academic and industry research Research into their mechanism of action in purified systems formed the base of her thesis work.

  • Receptor Signaling Bias: A Valuable and Accessible Property of New Drug Candidates | Dr. GPCR Ecosystem

    discovery at Glaxo (now GlaxoSmithKline) before joining UNC Chapel Hill, where he teaches and leads research discovery and development, with 25+ years of expertise and validated cell-based assays spanning basic research engagement opportunities for scientists and biotech leaders working across pharmacology, translational research intelligence on GPCR drug discovery trends and developments Expert-led webinars and masterclasses with leading researchers Cancel anytime. Sign Up for Free

  • Dr. Thomas P. Sakmar | Dr. GPCR Ecosystem

    and Ping Chi , that a mutant of CYSLTR2 is a driver oncogene in uveal melanoma, the most common eye cancer Sakmar on the web LinkedIn ResearchGate Pubmed ORCHID Google Scholar Rockefeller University Wikipedia

  • Dr. Marta Filizola | Dr. GPCR Ecosystem

    The overall goal of her research program is to obtain rigorous mechanistic insights into the structure at the Second University of Naples and a postdoctorate in Computational Biophysics at the Molecular Research Filizola on the web Icahn School of Medicine at Mount Sinai Filizola Lab Wikipedia Twitter Linkedin ResearchGate

  • Tuning GPCR System Sensitivity: Revealing True Drug Activity Through Functional Volume Control | Dr. GPCR Ecosystem

    discovery at Glaxo, now GlaxoSmithKline, before joining UNC Chapel Hill, where he teaches and leads research discovery and development, with 25+ years of expertise and validated cell-based assays spanning basic research engagement opportunities for scientists and biotech leaders working across pharmacology, translational research intelligence on GPCR drug discovery trends and developments Expert-led webinars and masterclasses with leading researchers Cancel anytime. Sign Up for Free

  • InĂŞs Pinheiro, Monserrat Avila Zozaya & Yamina Berchiche | Dr. GPCR Ecosystem

    As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the Yamina Berchiche on the web Website LinkedIn Facebook Twitter ResearchGate PubMed Google Scholar Dr.

  • Dr. Randy Hall | Dr. GPCR Ecosystem

    Randy has received a number of research prizes, including the PhRMA New Investigator Award, the Distinguished Young Scholar in Medical Research Award from the W.M. Randy Hall on the web Hall Lab LinkedIn Google Scholar ResearchGate Dr. Lefkowitz Memoir. Dr.

  • Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar & Ilana Kotliar | Dr. GPCR Ecosystem

    began as a focused exploration into Family B GPCRs evolved into a comprehensive resource for the GPCR research These tools are fully open to academic researchers , with wide applicability beyond just RAMPs — including Sakmar reflects on the generational shift in research culture. physician-scientist and Rockefeller University professor dedicated to drug discovery and chemical biology research Ilana’s research is multi-disciplinary and involves a close collaboration with the lab of proteomics

  • Dr. Alix A. J. Rouault | Dr. GPCR Ecosystem

    Olivier Mignen , the director of another research unit at the UBO recommended me to Dr. Julien Sebag , a researcher at the University of Iowa. I spent two years working with Dr. This project yielded my first, first author publication in BBA – Molecular Cell Research, and a book Rouault on the web University of Michigan Carver College of Medicine ResearchGate Google Scholar Dr.

  • Brian Bender: Computational Probes for Orphan GPCR | Dr. GPCR Ecosystem

    His research focuses on predicting GPCR structural ensembles from limited experimental data and using Connecting scientists is its own form of science Bender's role co-chairing the Gordon Research Seminar question 19:54 Joining UCSF and building the pan-GPCR docking pipeline 21:53 Co-chairing the Gordon Research then moved to the University of California in San Francisco to continue his training as a postdoctoral researcher Brian Bender on the web LinkedIn Twitter ResearchGate Dr.GPCR Member Google Scholar Dr.

  • Dr. Evi Kostenis | Dr. GPCR Ecosystem

    Research interests: Signaling mechanisms involving GPCRs and heterotrimeric G proteins" Dr. Evi Kostenis on the web University of Bonn ResearchGate LinkedIn Dr. GPCR Unlock the Full Dr.

  • Brian Arey: Discovering Signaling Bias at the FSH Receptor | Dr. GPCR Ecosystem

    But for the researcher who first encountered it not as a theory but as an anomalous bell-shaped dose-response Pharmacology within the Discovery and Optimization organization at Bristol-Myers Squibb, where he leads research work on circadian regulation of prolactin secretion at Florida State University before postdoctoral research His early work at Wyeth's Women's Health Research Institute produced foundational observations on biased physiologist's approach to mechanistic drug discovery The erosion of pharmacology training in pharmaceutical research

bottom of page